PL366298A1 - A stable pharmaceutical formulation comprising torsemide modification ii - Google Patents

A stable pharmaceutical formulation comprising torsemide modification ii

Info

Publication number
PL366298A1
PL366298A1 PL01366298A PL36629801A PL366298A1 PL 366298 A1 PL366298 A1 PL 366298A1 PL 01366298 A PL01366298 A PL 01366298A PL 36629801 A PL36629801 A PL 36629801A PL 366298 A1 PL366298 A1 PL 366298A1
Authority
PL
Poland
Prior art keywords
pharmaceutical formulation
stable pharmaceutical
torsemide modification
torsemide
modification
Prior art date
Application number
PL01366298A
Other languages
Polish (pl)
Inventor
Minutza Leibovici
Ruth Tenengauzer
Mira Kopel
Judith Aronhime
Marco Kordova
Original Assignee
Teva Pharmaceutical Industries Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharmaceutical Industries Ltd. filed Critical Teva Pharmaceutical Industries Ltd.
Priority to PL01366298A priority Critical patent/PL366298A1/en
Publication of PL366298A1 publication Critical patent/PL366298A1/en

Links

PL01366298A 2001-02-21 2001-02-21 A stable pharmaceutical formulation comprising torsemide modification ii PL366298A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL01366298A PL366298A1 (en) 2001-02-21 2001-02-21 A stable pharmaceutical formulation comprising torsemide modification ii

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL01366298A PL366298A1 (en) 2001-02-21 2001-02-21 A stable pharmaceutical formulation comprising torsemide modification ii

Publications (1)

Publication Number Publication Date
PL366298A1 true PL366298A1 (en) 2005-01-24

Family

ID=34432606

Family Applications (1)

Application Number Title Priority Date Filing Date
PL01366298A PL366298A1 (en) 2001-02-21 2001-02-21 A stable pharmaceutical formulation comprising torsemide modification ii

Country Status (1)

Country Link
PL (1) PL366298A1 (en)

Similar Documents

Publication Publication Date Title
GB0102342D0 (en) Pharmaceutical formulation
GB0319041D0 (en) Pharmaceutical Formulations
HK1068812A1 (en) Drug preparations
GB0118689D0 (en) Pharmaceutical formulation
PL366432A1 (en) Pharmaceutical formulation
GB0103638D0 (en) Pharmaceutical formulations
GB0121715D0 (en) Pharmaceutical formulations
GB0120701D0 (en) Pharmaceutical formulations
IL161306A0 (en) Pharmaceutical formulation comprising (r)-bicalutamide
HUP0303860A3 (en) A pharmaceutical tablet having a high active ingredient
GB2380129B (en) Pharmaceutical formulations
GB0105560D0 (en) Pharmaceutical formulations
HUP0600143A2 (en) A stable pharmaceutical formulation comprising torsemide modification ii
GB0014851D0 (en) Novel pharmaceutical formulation
PL366298A1 (en) A stable pharmaceutical formulation comprising torsemide modification ii
HRP20040757A2 (en) A stable pharmaceutical formulation comprising torsemide modification ii
GB0014883D0 (en) Novel pharmaceutical formulation
GB0014892D0 (en) Novel pharmaceutical formulation
GB0014947D0 (en) Novel pharmaceutical formulation
GB0124455D0 (en) Pharmaceutical formulations
GB0104749D0 (en) Pharmaceutical formulation
GB0014849D0 (en) Pharmaceutical aerosol formulation
EP1414417A4 (en) Pharmaceutical formulation
GB0014869D0 (en) Novel pharmaceutical formulation
GB0124712D0 (en) Pharmaceutical formulation

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)